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ABSTRACT
Introduction
Socioeconomic status (SES) is a well-known determinant of health, but its relation with vaccine-
induced immunity is less documented. We explored the association between SES and 
immunoglobulin G (IgG) levels against vaccine-preventable diseases in vaccinated children in 
the Dutch National Immunization Programme.
Methods
Data from a population-wide cross-sectional serosurvey in the Netherlands (2006-2007) were 
used. We compared geometric mean IgG concentrations/titers (GMC/T ratios) against measles, 
mumps, rubella, Haemophilus influenzae type b (Hib), Neisseria meningococcus type C, 
diphtheria, tetanus, poliovirus types 1,2,3 and pertussis in children of high versus low SES by 
linear regression analysis. We included 894 children (0-12 years) at one of two timeframes: 1 
month to 1 year, or 1-3 years after vaccination. Mother’s educational level and net household 
income served as binary indicators of SES.  
Results
Of 58 possible associations of vaccine-induced antibody responses with educational level and 
58 with income, 10 (9%) were statistically significant: 2 favouring (that is, with higher IgG levels 


































and polio 2 1m-1y after the 9-year booster dose (1.14, 1.01-1.27)) and 8 favouring low income 
(polio 1, 2 and 3 1m-1y after the 11-month booster (0.74, 0.58-0.94; 0.79, 0.64-0.97; 0.72, 0.55-
0.95), polio 3 and pertussis 1-3y after the 11-month booster (0.70, 0.56-0.88; pertussis-prn: 
0.60, 0.37-0.98; pertussis-ptx: 0.66, 0.47-0.95), mumps and rubella  1-3y after first vaccination 
(0.73, 0.55-0.97; 0.70, 0.55-0.90), and rubella 1m-1y after second vaccination (0.83, 0.55-
0.90)). After adjustment for multiple testing, none of the differences remained significant. There 
was no association between SES and proportion of children with protective IgG levels. 
Conclusion
In this explorative study, we found no consistent association between SES and immune 
response to vaccination in the Netherlands and no association with protective IgG levels. 
















Socioeconomic status (SES) is a well-known determinant of health [1]. It is a multi-faceted 
phenomenon that is at least partly captured by parameters such as education, occupational 
class and income. People with higher educational levels, from higher occupational classes and 
with higher income tend to have better health outcomes, although true causality is difficult to 
prove [2]. 
The association between SES and non-communicable diseases has been studied extensively 
[3], but less is known about the effect of socioeconomic status on acute infectious diseases, 
except for its relation with the risk of exposure (e.g. crowding) and with vaccination coverage 
[4,5]. In a recent study in the Netherlands, some differences in the incidence of self-reported, 
common infectious disease syndromes (acute upper and lower respiratory tract infections, acute
otitis media and urinary tract infections) were found between people from high versus low 
educational level, but they were not consistently in favour of either high or low educational level 
[6]. 
Exposure to stress of various nature early in life has been shown to programme the immune 
system [7]. Environmental factors, including exposure to pathogens, but also psychological 
stress, poor nutrition and smoking are thought to affect one’s immune response although it is 
not known to what extent [8,9]. The effect of SES on immunoglobulin-G (IgG) levels after natural
exposure was shown to be pathogen specific and not consistently pointing to one direction in a 
recent study among adults [10]. To study the effect of SES on immune response independently 
of its association with exposure, one could compare the immune response to (childhood) 
vaccination, particularly against diseases that are no longer endemic in the area, between low 
and high SES groups. Hence, exploring the relation between SES and immune response to 
vaccination provides additional insights that could help to disentangle the complex interaction 
between SES and communicable diseases. Moreover, it might be a first step towards optimizing
protection against vaccine preventable diseases in future. The aim of this study was to explore 
the possible association of mother’s educational level and net household income (as proxy 
indicators of SES) with immune response to vaccination in infants and children vaccinated 

































We used data from a population-wide cross-sectional serosurvey (the Pienter2 study) that was 
conducted in the Netherlands between February 2006 and June 2007. The aim of the Pienter2 
study was to establish a national serum bank to monitor antibody levels against vaccine-
preventable infectious diseases in the NIP [11]. For sampling in Pienter2, the Netherlands was 
divided in five regions and participants (0-79 years) were chosen from eight randomly selected 
municipalities in each region. People who agreed to participate, were asked to complete a 
questionnaire with questions on their background, immunisation status and health, and to 
donate a blood sample. For children younger than 14 years, a parent or guardian was asked to 
fill the questionnaire. In total, 19,781 people were invited to participate in Pienter2 which 
resulted in 6,348 (32%) completed questionnaires with supplementary blood samples, including 
an oversampling of non-Western migrants. The study was approved by the Medical Ethics 
Committee of the foundation of therapeutic evaluation of medicines (METC-STEG) in Almere 
(The Netherlands) [11]. 
For our study, only children from Pienter2 who were immunized according to the NIP were 
included. At the time of the study, the NIP included DTaP-IPV-Hib (Diphtheria, Tetanus, 
Pertussis, inactivated Poliovirus and Haemophilus influenza type b) infant vaccinations at 2, 3, 4
and 11 months (up to 1999 at 3, 4, 5 and 11 months; Hib included since 1993), and childhood 
booster vaccinations at 4 and 9 years of age for DT-IPV (since 1962). Since 2001, the booster 
vaccination at 4 years covers pertussis as well. From 2005 onwards, the pertussis component in
the DTP-IPV vaccine was changed from whole cell to acellular. The NIP also includes a MMR 
(measles, mumps, rubella) vaccine at the age of 14 months and 9 years. The MMR vaccine at 
14 months is combined with MenC vaccination (since 2002). Vaccination coverage at the age of
two years was 94.3% and 94.0% in respectively 2006 and 2007 for DTP-IPV, 95.4% and 95.0% 
for Hib, 94.8% and 95.6% for MenC and 95.4% and 95.9% for MMR. At the age of 10 years, 
vaccination coverage for DT-IPV was 93.0% and 92.5% and for MMR 92.9% and 92.5% [12].
Dates of vaccination were copied from the vaccination booklet that participants had to bring to 
the visit where the blood sample was collected, and checked afterwards in the digital national 
immunization register. We only included children whose blood sample was taken between 1 
month and 1 year (short-term) or between 1 and 3 years (medium-term) after infant vaccination 
(that is, primary series + booster dose at 11 months of DTP-IPV and Hib; first MMR and MenC 



































booster dose of DT-IPV at 9 years; second MMR at 9 years). Furthermore, to be included in the 
study, the age range within which vaccination had to be received, was 10-14 months for the first
booster vaccination of DTP-IPV (DTP-IPV4 scheduled at 11 months of age), 13-17 months for 
MMR1, 42-60 months for the 4-year booster vaccination of DT(P)-IPV, and 96-120 months for 
the 9-year booster of DT-IPV and MMR2. We excluded infants and children who reported to 
have been diagnosed with clinical pertussis or mumps.
  
Indicators of SES
We used educational level of the mother and net household income as two separate indicators 
of SES, since this information was requested in the Pienter2 questionnaire. Children of whom 
no information was available on one of these indicators, were excluded from analysis with that 
indicator. To be able to include a sufficient number of children in each stratum, the indicators of 
SES were used in a binary way: low-intermediate educational level (no education, primary 
education, junior technical school, or lower general or intermediate vocational secondary 
education) versus high educational level (higher vocational or higher general secondary 
education, pre-university or university education), and low-intermediate net household income 
(≤ € 3,050/month) versus high net household income (> € 3,050/month).
We repeated the analysis with a subset of children who belonged to the “low/intermediate-
category” for both educational level of the mother and net household income versus children 
who belonged to the “high-category” for both SES indicators to compare the extremes in a joint 
effect of educational level and household income.
Laboratory analysis
In the Pienter2 survey, IgG levels were determined by a fluorescent bead-based multiplex 
immunoassay (MMRV-MIA) using Luminex for simultaneous detection of antibodies against 
measles, mumps and rubella [13]. Antibodies against MenC and Hib were measured in a similar
way, using combined assays [14]. Pentaplex MIA was used to determine IgG levels against 
pertussis (pertussis toxin (ptx), pertactin (prn) and filamentous hemagglutinin (FHA)), diphtheria,
and tetanus [15]. Polio IgG total antibody levels (against poliovirus types 1, 2, and 3) were 
measured with a standard neutralization test [16]. The IgG concentrations were determined and 





































We described the study population included after infant and childhood vaccination with 
descriptive statistics. We calculated geometric mean IgG titers/concentrations (GMC/T; with 
95% confidence intervals) for each pathogen at the two timeframes (1 month-1 year and 1-3 
years) after infant and childhood vaccination. We used linear regression analyses and 
calculated GMC/T ratios (GMC/T in the high SES groups divided by GMC/T in the low SES 
groups) to assess the effect of educational level of the mother, net household income and the 
combination of both, on logarithmically transformed IgG concentrations for the different 
pathogens at the two timeframes after vaccination. A GMC/T ratio > 1 “favoured” high 
educational level or household income (that is, antibody concentrations were higher in the high 
SES group than the low SES group). Multivariable linear regression was performed to correct 
for migration background, sex and (exact) age at vaccination. We corrected for multiple testing 
by applying the Benjamini-Hochberg’s procedure on the p-values for the individual differences in
GMC/T between low and high educational level, household income and the combination of both 
[17].
We compared the proportions of individuals with protective levels of IgG against the different 
pathogens between children from low-intermediate (hereafter: low) and high household income, 
and between children with mothers with low-intermediate (low) and high educational level [18-
25]. 
The survey design of Pienter2 with five regions (strata) and 40 municipalities (clusters) was 
taken into account in all analyses by adding them as random effects, correcting the standard 
error of the estimates. The analyses were conducted in Stata version SE/15.1 (StataCorp LLC, 
Texas, USA).
Validation of results with Pienter1 data
We repeated the analyses with data from the Pienter1 study, which was conducted between 
October 1995 and December 1996 and covered data from 8,539 participants (response rate 
56%).The Pienter1 study design was similar to Pienter2 and has been described elsewhere 
[26]. In Pienter1, only data on mother’s educational level (not on household income) was 
available. At the time of the Pienter1 study, vaccination with DTP-IPV started at 3 months of age
(3, 4, 5, and 11 months) and only the whole cell pertussis vaccine was used. MenC vaccination 
was not yet part of the NIP. Antibody levels against diphtheria and tetanus were determined 
using toxin binding inhibition assays in Pienter1; antibodies against polio by neutralization tests, 
and antibodies against measles, mumps, rubella and Hib by ELISAs [27]. For pertussis, only 






































For the analyses by educational level, we included between 65 and 113 infants and children in 
the timeframe 1m-1y after vaccination per pathogen and between 141 and 232 infants and 
children in the timeframe 1-3y after vaccination per pathogen. For the analyses by net 
household income, these numbers were 46-101 and 117-191 respectively (Supplementary 
tables 1 and 2). Data on net household income were missing more often than data on 
educational level of the mother, which explains the difference in number of infants and children 
included. The characteristics of the study population are shown in tables 1 and 2. As expected, 
mother’s educational level and net household income were correlated: infants and children of 
mothers with a low educational level were more often living in a family with a low net household 
income than infants and children of mothers with high educational level (table 1), and vice versa
(table 2). There were significantly more children born outside the Netherlands in the low income 
and low educational level groups than in the high income and educational level groups. 
GMC/T ratios
In figures 1 and 2, GMC/T ratios with 95% confidence intervals (CI) are presented for high 
versus low educational level of the mother and net household income respectively. A ratio >1 
means that antibody levels are higher in children with high educational level of the mother or 
with high net household income, i.e. a ratio >1 favours a high level of SES. In the analysis by 
educational level of the mother (figure 1), the GMC/T ratio (and 95% CI) was >1 for Hib 1m-1y 
after vaccination (GMC/T ratio 2.99, 95% CI 1.42-6.30) and polio 2 virus 1m-1y after the 9-year 
booster vaccination (1.14, 1.01-1.27). In the analysis by net household income (figure 2), the 
GMC/T ratio was <1 for polio 1, 2 and 3 virus 1m-1y after the 11-month booster vaccination 
(polio 1: 0.74, 0.58-0.94; polio 2: 0.79, 0.64-0.97; polio 3: 0.72, 0.55-0.95) and for polio 3 virus 
also 1-3y after the 11-month booster vaccination (0.70, 0.56-0.88). In addition, the GMC ratio 
was <1 for pertussis prn ad ptx 1-3y after the 11-month booster vaccination (prn: 0.60, 0.37-
0.98; ptx: 0.66, 0.47-0.95), for mumps 1-3 y after first vaccination (0.73, 0.55-0.97), and for 
rubella 1-3 y after first vaccination (0.70, 0.55-0.90) and 1m-1y after second vaccination (0.83, 
0.55-0.90). 
In the analysis by SES (educational level of the mother and net household income combined), 


































booster vaccination were <1 (rubella: 0.73, 0.55-0.97; polio 3: 0.68, 0.50-0.94; Supplementary 
figure 1). No other associations were found.
After correcting for sex, migration background and age at vaccination in multivariable linear 
regression analysis, the differences in GMC/T ratio by educational level remained only 
significant for Hib, 1m-1y after vaccination(3.88; 1.97-7.66) and polio 2, 1m-1y after the 9-year 
booster (1.15; 1.02-1.30), and by net household income for polio 1 and 3, 1m-1y after the 11-
month booster dose (resp. 0.72; 0.58-0.91 and 0.73;  0.54-0.99) (Supplementary figures 2-7). In
the multivariable regression analysis, some other differences became significant. In the 
analyses by educational level of the mother, the adjusted GMC/T ratio was 1.72 (1.07-2.76) for 
diphtheria 1m-1y after the 11-month booster vaccination, 1.36 (1.04-1.78) for tetanus and 1.23 
(1.00-1.50) for polio 2 virus 1-3y after the 11-month booster vaccination. 
After adjustment for multiple testing by applying the Benjamini-Hochberg’s procedure, none of 
the differences in GMC/T between the high and low SES groups, neither in the univariable 
analyses nor in the multivariable analyses, were significant.
Proportions reaching protecting IgG levels
No differences were observed in proportions of infants and children reaching protective IgG 
levels with mothers of  low versus high educational level, except for IgG levels against rubella. 
For rubella, 100% of infants of mothers with low educational level and 96% of infants of mothers
with high educational levels reached IgG levels above the threshold for protection 1-3y after the 
first vaccination (p=0.02; table 3). In the analysis by net household income, 67% of infants from 
low income households and 50% of infants from high income households reached levels of 
protection against polio 3 virus 1-3 years after infant vaccination (p=0.04). The proportion of 
children with protective IgG levels against polio 3 is low in all children 1-3y after infant 
vaccination, but increases thereafter (table 3). This was also shown in previous studies using 
these data [28]. For the other pathogens, there were no significant differences in proportions of 
infants and children reaching protective IgG levels at the different timeframes. After adjustment 
for multiple testing, the differences between the high and low SES groups disappeared.
Validation of results with Pienter1 data
The analyses by educational level of the mother were repeated with Pienter1 data on 581 
infants aged approximately 0-4 years and 494 children 4-12 years (a total of 1,075 children). 
None of the differences in IgG levels found between children of mothers from high versus low 



































differences were found in the Pienter1 study that were not found in Pienter2: the GMC ratios 
and 95% CI were >1 for polio 1, 2 and 3 virus 1m-1y after the 11-month booster vaccination 
(resp. 1.43 (1.03-2.01); 1.46 (1.03-2.12); and 1.57 (1.04-2.34)). These differences remained 









In this study, we explored the effect of two indicators of SES (educational level and net 
household income) on immune response to vaccination in infants and children vaccinated 
according to the Dutch NIP. No consistent patterns were observed that favoured either high or 
low SES for any of the studied pathogens at either timeframe (1 month to 1 year after 
vaccination and 1 to 3 years after vaccination). Although a few significant differences in GMC/T 
were found for some pathogens at some timeframes, these differences were not consistent over
timeframes, nor observed after both infant and childhood vaccination. Moreover, repetition of 
the analyses with data from the Pienter1 serosurvey that was conducted ten years earlier did 
not show similar differences but rather a few other inconsistent differences. After adjusting for 
multiple testing, all significant differences disappeared, confirming the irrelevance of the few 
differences found in the individual comparisons. The proportion of infants and children with 
protective IgG levels against the different pathogens did not differ significantly between high and
low SES, except for slight differences for rubella and polio 3.
Many factors may affect immune response to vaccination. Whereas there is strong evidence 
about the effect of intrinsic factors (such as age and genetics), comorbidity and vaccine factors 
on immune response to vaccination, the evidence about the relation with socioeconomic factors 
such as nutritional status and educational level is ambiguous [9].  Studying associations 
between SES and health is complicated since several mediators and moderators along the 
causal pathway should be considered [2]. Studies that explore the association between SES 
and health outcomes often use educational level, income and occupation as indicators of SES, 
not in the least because they are measurable and can be addressed in policies. Whereas 
education may impact health/lifestyle behaviour, it also affects income and occupation [29]. In 
our study, low educational level was indeed associated with low net household income. 
Household income and occupation affect healthcare seeking behaviour and lifestyle, but also 
influence living conditions (e.g. crowding) and the risk of exposure to hazardous factors 
including pathogens [2, 29]. For example, several studies have shown that low SES (expressed 
in factors such as sole-parent households, maternal education, car ownership) is associated 
with increased risk of acquiring pneumococcal, Hib and meningococcal disease in the 
community [30-32].  
In a study in the Netherlands, weak associations were found between SES (educational level 
and income) and IgG concentrations induced by natural infections with rubella, measles, 
pneumococcus, Hib and MenC in non-vaccinated adults, although the direction of the 



































against CMV were found in adults >25 years with lower education or income [33]. However, the 
relative contributions of differences in pathogen exposure versus differences in immune 
response after natural exposure, were difficult to assess in these studies. 
Little is known to what extent SES affects humoral immunity independently of the risk of 
exposure. By looking at the immune response after vaccination, differences in exposure can be 
ruled out, at least for vaccine-preventable diseases that are no longer prevalent in the study 
population (such as rubella, diphtheria and polio in the Netherlands). Our results do not point 
towards a clinically significant impact of SES on humoral immunity to these vaccine-preventable
diseases in Dutch children. 
Our study had several strengths. First, we were able to use data from a national serosurvey in a
representative sample of the Dutch population, including detailed and verified information on 
dates of vaccination for each included child [11]. Moreover; we were able to include children at 
two different timeframes after vaccination (1 month to 1 year, and 1-3 years). This allowed us to 
look at possible differences in the short versus medium-long term effects after vaccination. In 
addition, we were able to validate our results by repeating the analysis with data from the 
previous national serosurvey (10 years earlier) [26, 27]. 
The study also had some limitations. As proxies for SES, only mother’s educational level and 
net household income were available from the Pienter2 study. Data on possible mediators and 
moderators between these indicators and immune response to vaccination, such as nutritional 
status, smoking and alcohol use, was not collected in the Pienter2 study. Hence, even if we had
found a clear association between education/income and immune response, we would not have 
been able to interpret this in terms of causality; additional studies with another design would be 
needed for this. 
Not for all children in the Pienter2 study, data was available on net household income. This 
resulted in smaller groups for the analysis by income and larger confidence intervals. Since 
people with a low income may be less eager to report on their income than people with higher 
incomes, the low income group may have been an underrepresentation of reality (selection 
bias). Due to small numbers in each group, we were not able to include more than two 
categories for education and net household income (low-intermediate versus high). By using 
two instead of several categories for educational level and income, we were not able to 
compare the highest versus the lowest levels of SES only, meaning that we might have missed 
differences only apparent when comparing the extremes. We compensated for this by also 
comparing GMC/T ratios in the low educational level plus low income group versus the high 



































in SES, such as the Netherlands, differences in immune response may be more difficult to 
detect.
Every child was sampled only once in this cross-sectional study, meaning that every child was 
included in only one timeframe after vaccination. Thus, the two timeframes (1m-1y and 1-3y) 
could not be compared directly as data in the two timeframes were from two different groups of 
children. On the other hand, within each timeframe the data were correlated (IgG levels against 
different pathogens measured in each sample). The latter implies that an outlier in IgG level 
against one pathogen would likely be an outlier in IgG levels against other pathogens as well if a
general factor such as SES would be the cause of this. We did not verify this at the individual 
level. 
Also, we aimed to look at immune response to vaccination only, interference with natural 
exposure to pathogens that are still circulating in the Netherlands (such as Bordetella pertussis, 
measles and mumps virus) could not be ruled out completely. Individuals who self-reported to 
have been diagnosed with clinical pertussis or mumps (resp. n=3 and n=0) were excluded from 
analysis, but we could not take into account possible natural boostering of immunity. In a 
previous study with Pienter2 data, an association was found between self-reported coughing > 2
weeks in the previous 12 months and higher pertussis ptx IgG levels [34]. Although we had 
access to this information, we decided not to exclude children of whom parents reported 
coughing > 2 weeks, since that would have meant that we had to exclude about 25% of our 
study population. However, there was no difference in the numbers of infants and children with 
> 2 weeks coughing between high and low SES.
Finally, we only considered the effect of SES on humoral immune response (IgG levels) to 
vaccination, which is still the most conventional response to investigate. However, vaccine 
response can also be quantified by looking at cellular and cytokine responses, and responses of
the innate immune system [9]. Future studies should take this complex interplay of the different 
parts of the immune system into account. 
In conclusion, this explorative study did not provide evidence for an association between SES 
and immune response to infant and childhood vaccination in the first three years after infant and
childhood vaccination. Additional studies in other settings with data collected specifically for this 
purpose should confirm this. Moreover, it  would be interesting to look at the longer term 
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TABLE 1. Characteristics of all infants and children included in timeframes 1m-1y (n=358) and 1-3y (n=536) after vaccination 
according to NIP by educational level of mother











N % n % p-value n % n % p-value
Total 190 53% 168 47% - 327 61% 209 39% -
Male sex 92 48% 89 53% 0.27 157 48% 103 49% 0.81














Indigenous Dutch 123 65% 135 80%
0.002
199 61% 162 78%
0.004
1st generation other western 0 0% 1 0.6% 1 0.3% 1 0.5%
2nd generation other western 4 2% 11 7% 12 4% 14 7%
1st generation Moroccan or 
Turkish
2 1% 1 0.6% 20 6% 2 1%
2nd generation Moroccan or 
Turkish
28 15% 1 0.6% 26 8% 1 0.5%
1st generation Surinam or Aruban 
or Dutch Antillean
4 2% 2 1% 16 5% 8 4%
2nd generation Surinam or Aruban 
or Dutch Antillean
16 8% 6 4% 23 7% 8 4%
1st generation other non-western 2 1% 3 2% 14 4% 8 4%
2nd generation other non-western 11 6% 8 5% 16 5% 5 2%
Urbanization Very high 35 18% 31 18%
0.97
58 18% 38 18%
0.96
High 58 31% 54 32% 117 36% 71 34%
Moderate 35 18% 28 17% 65 20% 45 22%




High 17 9% 73 43%
<0.001
29 9% 78 37%
<0.001Low 128 67% 71 42% 228 70% 101 48%





DTP-IPV 11 m 11 (10-13) 11 (10-13) 0.25 n.a. n.a. -
DTP-IPV 4 y n.a. n.a. - 46 (44-51) 46 (44-54) 0.11
DT-IPV 9 y n.a. n.a. - 107 (99-116) 107 (99-114) 0.98
MMR1 14 (12-16) 14 (13-16) 0.63 n.a. n.a. -
MMR2 n.a. n.a. - 107 (100-116) 107 (100-114) 0.96
473
474
percentile) MenC 14 (14-16) 14 (14-16) 0.58 n.a. n.a. -
Hib 11 (10-13) 11 (10-13) 0.059 n.a. n.a. -
475
476
TABLE 2. Characteristics of all infants and children included in timeframes 1m-1y (n=294) and 1-3y (n=438) after vaccination 
according to NIP by net household income










N % n % p-value n % n % p-value
Total 203 69% 91 31% - 331 75% 107 24% -
Male sex 102 50% 48 53% 0.67 155 47% 55 51% 0.47














Indigenous Dutch 122 60% 80 88%
0.02
192 58% 93 87%
0.007
1st generation other western 0 0% 1 1% 1 0.3% 1 0.9%
2nd generation other western 10 5% 7 8% 16 5% 6 6%
1st generation Moroccan or 
Turkish
3 1% 0 0% 18 5% 0 0%
2nd generation Moroccan or 
Turkish
26 13% 0 0% 23 7% 0 0%
1st generation Surinam or Aruban 
or Dutch Antillean
6 3% 0 0% 18 5% 3 3%
2nd generation Surinam or Aruban 
or Dutch Antillean
18 9% 2 2% 25 8% 2 2%
1st generation other non-western 6 3% 0 0% 18 5% 2 2%
2nd generation other non-western 12 6% 1 1% 20 6% 0 0%
Urbanization Very high 42 21% 18 20%
0.51
63 19% 21 20%
0.75
High 56 28% 35 38% 112 34% 43 40%
Moderate 39 19% 13 14% 68 21% 22 21%
Low 66 33% 91 31% 88 27% 21 20%
Educational 
level mother
High 128 63% 17 19%
<0.001
101 31% 78 73%
<0.001Low 71 35% 73 80% 228 69% 29 27%






DTP-IPV 11 m 11 (10-13) 11 (10-13) 0.39 n.a. n.a. -
DTP-IPV 4 y n.a. n.a. - 46 (44-52) 46 (44-50) 0.55
DT-IPV 9 y n.a. n.a. - 107 (99-114) 107 (100-114) 0.89
MMR1 14 (14-16) 14 (13-16) 0.81 n.a. n.a. -
MMR2 n.a. n.a. - 107 (100-115) 107 (100-114) 0.39
MenC 14 (14-16) 14 (14-16) 0.89 n.a. n.a. -
477
478
Hib 11 (10-13) 11 (10-13) 0.17 n.a. n.a. -
479
480
TABLE 3. Comparison of proportions of infants and children with protective IgG levels by educational level of mother and net 
household income















Vaccination n/N % n/N % p-value n/N % n/N % p-
value







100% 54/54 100% -
BMR2, 1m-1y 62/62 100% 25/25 100% - 56/56 100% 13/13 100% -
BMR2, 1-3 y 86/86 100% 68/69 99% 0.25 88/88 100% 30/30 100% -
Mumps ≥45 RU/ml BMR1, 1m-1y 40/43 93% 36/41 88% 0.42 37/39 95% 24/27 89% 0.36
BMR1, 1-3y 112/12
6
89% 88/103 85% 0.48 121/13
5
90% 46/54 85% 0.24
BMR2, 1m-1y 60/62 97% 25/25 100% 0.37 55/56 98% 12/13 92% 0.26
BMR2, 1-3 y 84/86 98% 68/69 99% 0.71 86/88 98% 30/30 100% 0.39
Rubella ≥10 IU/ml BMR1, 1m-1y 43/43 100% 41/41 100% - 39/39 100% 27/27 100% -
BMR1, 1-3y 126/12
6
100% 99/103 96% 0.02 134/13
5
99% 53/54 98% 0.49
BMR2, 1m-1y 61/62 98% 25/25 100% 0.54 55/56 98% 13/13 100% 0.53
BMR2, 1-3 y 85/86 99% 67/69 97% 0.45 87/88 99% 29/30 97% 0.41
Diphtheria ≥0.01 IU/ml DTP-IPV 11 m, 
1m-1y
38/40 95% 48/48 100% 0.09 43/45 96% 28/28 100% 0.19




91% 78/88 89% 0.61 108/12
2
89% 39/44 89% 0.98
DTP-IPV 4 y, 1m-
1y
70/70 100% 43/43 100% - 75/75 100% 26/26 100% -
DTP-IPV 4 y, 1-3y 95/96 99% 66/67 99% 0.79 98/98 100% 35/36 97% 0.13
481
482
DT-IPV 9 y, 1m-1y 53/53 100% 24/24 100% - 48/48 100% 12/12 100% -
DT-IPV 9 y, 1-3y 83/83 100% 68/68 100% - 87/87 100% 30/30 100% -
Tetanus ≥0.01 IU/ml DTP-IPV 11 m, 
1m-1y
40/40 100% 48/48 100% - 45/45 100% 28/28 100% -




100% 88/88 100% - 122/12
2
100% 44/44 100% -
DTP-IPV 4 y, 1m-
1y
69/69 100% 43/43 100% - 75/75 100% 26/26 100% -
DTP-IPV 4 y, 1-3y 95/95 100% 67/67 100% - 98/98 100% 35/35 100% -
DT-IPV 9 y, 1m-1y 53/53 100% 24/24 100% - 48/48 100% 12/12 100% -
DT-IPV 9 y, 1-3y 83/83 100% 68/68 100% - 87/87 100% 30/30 100% -
Polio 1 Log2≥3 DTP-IPV 11 m, 
1m-1y
39/40 98% 47/48 98% 0.90 44/45 98% 27/28 96% 0.73




90% 82/88 93% 0.50 113/12
2
93% 39/44 89% 0.35
DTP-IPV 4 y, 1m-
1y
70/70 100% 43/43 100% - 75/75 100% 26/26 100% -
DTP-IPV 4 y, 1-3y 94/96 98% 66/67 99% 0.78 95/98 97% 36/36 100% 0.37
DT-IPV 9 y, 1m-1y 53/53 100% 24/24 100% - 48/48 100% 12/12 100% -
DT-IPV 9 y, 1-3y 82/83 99% 69/69 100% 0.36 87/87 100% 30/30 100% -
Polio 2 Log2≥3 DTP-IPV 11 m, 
1m-1y
40/40 100% 47/48 98% 0.36 45/45 100% 27/28 96% 0.21




85% 80/88 91% 0.26 106/12
2
87% 39/44 89% 0.72
DTP-IPV 4 y, 1m-
1y
70/70 100% 42/43 98% 0.16 75/75 100% 25/26 96% 0.06
DTP-IPV 4 y, 1-3y 95/96 99% 67/67 100% 0.42 98/98 100% 35/36 97% 0.13
DT-IPV 9 y, 1m-1y 53/53 100% 24/24 100% - 48/48 100% 12/12 100% -
DT-IPV 9 y, 1-3y 82/83 99% 69/69 100% 0.36 87/87 100% 30/30 100% -
Polio 3 Log2≥3 DTP-IPV 11 m, 
1m-1y
38/40 95% 44/48 92% 0.56 44/45 98% 24/28 86% 0.06
DTP-IPV 11 m, 1-
3y
77/119 65% 49/88 56% 0.27 82/122 67% 22/44 50% 0.04
DTP-IPV 4 y, 1m- 64/70 91% 35/43 81% 0.19 67/75 89% 22/26 85% 0.51
1y
DTP-IPV 4 y, 1-3y 78/96 81% 52/67 78% 0.57 79/98 81% 28/36 78% 0.75
DT-IPV 9 y, 1m-1y 53/53 100% 23/24 96% 0.16 48/48 100% 12/12 100% -
DT-IPV 9 y, 1-3y 79/83 95% 67/69 97% 0.57 85/87 98% 28/30 93% 0.28
Pertussis-
prn
≥25 EU/ml DTP-IPV 11 m, 
1m-1y
24/29 83% 30/36 83% 0.95 31/35 89% 13/18 72% 0.15
DTP-IPV 11 m, 1-
3y
15/110 14% 14/85 16% 0.60 19/112 17% 5/42 12% 0.43
DTP-IPV 4 y, 1m-
1y
42/69 61% 31/45 69% 0.35 44/74 59% 19/25 76% 0.05
DTP-IPV 4 y, 1-3y 43/88 49% 29/53 55% 0.55 47/86 55% 14/31 45% 0.51
Hib ≥0.15 µg/ml Hib 1m-1y 34/39 87% 46/48 96% 0.19 40/45 89% 27/28 96% 0.27
Hib 1-3y 96/116 83% 84/93 90% 0.13 100/11
7
85% 43/49 88% 0.72
MenC ≥2 µg/ml MenC 1m-1y 23/43 53% 22/42 52% 0.91 24/41 59% 14/26 54% 0.66




































































































FIGURE 2. GMC ratios: high versus intermediate/low net household income, with 95% confidence intervals512
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